Toxic conjunctivitis (ocular surface medicamentosa, toxic keratoconjunctivitis)
Ocular surface · Ophthalmology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Direct toxic/irritant (± delayed hypersensitivity) damage to the ocular surface from chronic topical eye medications or their preservatives (especially benzalkonium chloride). Mimics allergic conjunctivitis; classically occurs in glaucoma or dry-eye patients on long-term multiple drops. DRAFT for clinician review.
Red flags
- Large corneal epithelial erosion or ulceration
- Pseudodendrites (rolled degenerated epithelium — may be confused with herpetic dendrites)
- Decreased vision
- Failure to resolve after stopping drops (reconsider infection or ocular cicatricial pemphigoid)
Assessment
Differential diagnosis
- Seasonal/perennial allergic conjunctivitis
- Vernal keratoconjunctivitis
- Atopic keratoconjunctivitis
- Giant papillary conjunctivitis
- Hypersensitivity (allergic) reaction to a drop (occurs early vs toxic which is late)
- Conjunctivitis medicamentosa (vasoconstrictor overuse)
- Dry eye disease
- Early ocular cicatricial pemphigoid
Investigations
- History: symptoms worsened with continued drop use after initial improvement; tally all topical ocular meds, preservatives, duration
- Slit-lamp: conjunctival hyperemia, chemosis, papillary reaction, punctate epithelial staining on fluorescein, erosions
- Schirmer test, tear break-up time, lissamine green staining
- Patch testing rarely helpful (local reaction)
- Diagnosis confirmed when stopping the offending drop resolves it
Management
- Identify and stop as many topical agents/preservatives as feasible
- Switch to preservative-free formulation or an oral alternative
- Cold compresses + preservative-free artificial tears/ointment
- Ophthalmology monitoring (rule out an infectious cause)
- Topical corticosteroid for moderate–severe cases (ophthalmologist) with IOP monitoring
Drugs & doses
Discontinue the offending drop(s); substitute a preservative-free formulation or oral equivalent where possible.
Preservative-free artificial tears/ointment + cold compresses — symptomatic relief.
Topical corticosteroid for moderate–severe disease (OPHTHALMOLOGIST) — short course, typically 2–6 weeks, 1–4×/day (1–2×/day in mild cases). Options: loteprednol etabonate 0.5% gel or 0.38%, loteprednol ointment (BAK-free), prednisolone sodium phosphate 0.5% (BAK-free), or a preservative-free steroid. In glaucoma / steroid-IOP risk, prefer loteprednol (and gel/0.38% over suspension). Monitor intraocular pressure.
Disposition
Discharge after stopping the offending agent, with ophthalmology follow-up. Refer to a corneal specialist if dry eye versus toxic conjunctivitis is unclear or if topical steroids are required.
Complications & pitfalls
- Corneal erosion/ulceration
- Visual dysfunction
- Chronic ocular surface disease
- Steroid-induced raised intraocular pressure
Exam pearls
- Suspect in any red eye on chronic preservative-containing drops — especially glaucoma patients on multiple drops
- The history 'improved, then got worse with continued use' is the tell
- Benzalkonium chloride is the usual culprit preservative
- Not allergic — patch testing is usually unhelpful
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.